Clinical Trials Directory

Trials / Unknown

UnknownNCT03932123

Antibiotic Therapy for Early Onset Neonatal Sepsis

Efficacy and Safety of Antibiotics in the Treatment of Early Onset Neonatal Sepsis

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Shandong University · Academic / Other
Sex
All
Age
0 Days – 3 Days
Healthy volunteers
Not accepted

Summary

Antibiotic therapy for early onset neonatal sepsis recommended by international guidelines and relevant studies is only kind of treatment regimen that penicillin G/ penicillin/ampicillin combined with gentamicin as the first-line treatment regimen. However, it is not applicable to the clinical practice in many countries and regions. We aim to study efficacy and safety of antibiotics in the treatment of early onset neonatal sepsis.

Conditions

Interventions

TypeNameDescription
DRUGPiperacillin and tazobactam, azlocillin, latamoxef, meropenem, vancomycin,cefotaximeEfficacy and safety of antibiotics

Timeline

Start date
2019-05-05
Primary completion
2025-10-01
Completion
2025-12-01
First posted
2019-04-30
Last updated
2021-04-20

Locations

1 site across 1 country: China

Regulatory

Source: ClinicalTrials.gov record NCT03932123. Inclusion in this directory is not an endorsement.